Oracle Healthcare Acquisition Corp. Sets Record Date for Determination of Stockholders Entitled to Receive Liquidating Distribut
05 5월 2008 - 9:08PM
PR Newswire (US)
GREENWICH, Conn., May 5 /PRNewswire-FirstCall/ -- Oracle Healthcare
Acquisition Corp. (the "Company") (OTC:OHAQ) (BULLETIN BOARD: OHAQ)
announced today that the Company has set the close of business on
May 7, 2008 as the record date for the determination of
stockholders entitled to receive a liquidating distribution, if
any, from the trust account in which the proceeds from the
Company's initial public offering were placed, pursuant to the
proposed Plan of Liquidation of the Company. The dissolution and
Plan of Liquidation of the Company are subject to stockholder
approval, for which the Board of Directors of the Company has
called a special meeting of stockholders to be held on May 7, 2008.
As of May 7, 2008, the share transfer books of the Company will be
closed if the dissolution and Plan of Liquidation are approved by
the Company's stockholders. The Company filed a definitive proxy
statement with the U.S. Securities and Exchange Commission (the
"SEC") on Schedule 14A on April 16, 2008 regarding the proposed
dissolution and Plan of Liquidation of the Company. Stockholders
and investors are encouraged to read the definitive proxy statement
because it contains important information regarding the proposed
dissolution and Plan of Liquidation of the Company. Investors are
able to obtain free copies of the proxy statement as well as other
filed documents containing information about the Company at
http://www.sec.gov/, the SEC's Web site. Forward Looking
Statements: This press release contains includes forward-looking
statements within the meaning of Section 27A of the Securities Act
of 1933, as amended, and Section 21E of the Securities Exchange Act
of 1934, as amended. Readers are cautioned not to place undue
reliance on any such forward-looking statements, each of which
speaks only as of the date made. Such statements are subject to
certain risks and uncertainties which are disclosed in the
Company's SEC reports, including the Form 10-K for the year ended
December 31, 2007 and definitive proxy statement on Schedule 14A
filed with the SEC on April 16, 2008. Contact: Joel D. Liffmann
President and Chief Operating Officer Oracle Healthcare Acquisition
Corp. (203) 862-7900 DATASOURCE: Oracle Healthcare Acquisition
Corp. CONTACT: Joel D. Liffmann of Oracle Healthcare Acquisition
Corp., President and Chief Operating Officer, +1-203-862-7900
Copyright